Correlation Between Opthea and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Opthea and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and TC BioPharm plc, you can compare the effects of market volatilities on Opthea and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and TC BioPharm.

Diversification Opportunities for Opthea and TC BioPharm

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Opthea and TCBPW is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of Opthea i.e., Opthea and TC BioPharm go up and down completely randomly.

Pair Corralation between Opthea and TC BioPharm

Considering the 90-day investment horizon Opthea is expected to generate 61.03 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, Opthea is 24.06 times less risky than TC BioPharm. It trades about 0.05 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.71  in TC BioPharm plc on October 2, 2024 and sell it today you would earn a total of  0.18  from holding TC BioPharm plc or generate 25.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy91.96%
ValuesDaily Returns

Opthea  vs.  TC BioPharm plc

 Performance 
       Timeline  
Opthea 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opthea has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
TC BioPharm plc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

Opthea and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Opthea and TC BioPharm

The main advantage of trading using opposite Opthea and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Opthea and TC BioPharm plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity